Testing effectiveness (Phase 2)Looking for participantsNCT06992258
What this trial is testing
Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer
Who this might be right for
Colorectal Cancer
Criterium, Inc. 120